Irene T. Weber mainly focuses on Protease, HIV-1 protease, Stereochemistry, Binding site and HIV Protease Inhibitor. Her Protease research focuses on Proteases and how it connects with Homology modeling, Rous sarcoma virus and Wild type. The various areas that Irene T. Weber examines in her HIV-1 protease study include Mutant and Enzyme inhibitor.
The Stereochemistry study combines topics in areas such as Crystallography, Beta sheet and Hydrogen bond. Her Binding site research is under the purview of Biochemistry. The concepts of her HIV Protease Inhibitor study are interwoven with issues in Darunavir and Saquinavir.
Her main research concerns Protease, HIV-1 protease, Stereochemistry, Biochemistry and HIV Protease Inhibitor. Her Protease research includes themes of Darunavir, Mutant and Virology. Her Darunavir research focuses on Saquinavir and how it relates to Protease inhibitor.
In her study, Protein structure and Dissociation constant is strongly linked to Crystallography, which falls under the umbrella field of HIV-1 protease. Her biological study spans a wide range of topics, including Hydrolase, Active site, Substrate, Hydrogen bond and Binding site. Irene T. Weber combines subjects such as Potency and Enzyme inhibitor with her study of HIV Protease Inhibitor.
Irene T. Weber mostly deals with Protease, HIV-1 protease, Stereochemistry, HIV Protease Inhibitor and Active site. Her Protease research is classified as research in Biochemistry. Irene T. Weber has included themes like Hydrolase, Darunavir and Hydrogen bond in her HIV-1 protease study.
Her Stereochemistry research is multidisciplinary, incorporating elements of Design synthesis, Protein structure, Biological evaluation, Structure–activity relationship and Binding site. Her research in HIV Protease Inhibitor intersects with topics in Proteases and Potency. Her Active site study incorporates themes from Oxidoreductase, Cofactor, Flavin group and Molecular mechanics.
The scientist’s investigation covers issues in Protease, HIV-1 protease, Stereochemistry, Active site and HIV Protease Inhibitor. Her Protease research is multidisciplinary, incorporating perspectives in Wild type, Aspartic acid and Virology. Her HIV-1 protease research includes elements of Darunavir and Binding site.
As part of one scientific family, Irene T. Weber deals mainly with the area of Stereochemistry, narrowing it down to issues related to the Protein structure, and often Oxidoreductase, Substrate, Drug resistance, Crystallography and Amprenavir. While the research belongs to areas of Active site, Irene T. Weber spends her time largely on the problem of Hydrolase, intersecting her research to questions surrounding Mutation and Hydrogen bond. Her studies in HIV Protease Inhibitor integrate themes in fields like Proteases, Potency, Orders of magnitude, AIDS therapy and Drug target.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease
Alexander Wlodawer;Maria Miller;Mariusz Jaskólski;Bangalore K. Sathyanarayana.
Science (1989)
The structure of the E. coli recA protein monomer and polymer.
Randall M. Story;Irene T. Weber;Irene T. Weber;Thomas A. Steitz.
Nature (1992)
Structure of a complex of catabolite gene activator protein and cyclic AMP refined at 2.5 A resolution.
Irene T. Weber;Thomas A. Steitz.
Journal of Molecular Biology (1987)
Crystal structure of interleukin 8: symbiosis of NMR and crystallography.
E T Baldwin;I T Weber;R St Charles;J C Xuan.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro
Yasuhiro Koh;Hirotomo Nakata;Kenji Maeda;Hiromi Ogata.
Antimicrobial Agents and Chemotherapy (2003)
Model structure of decorin and implications for collagen fibrillogenesis.
Irene T. Weber;Robert W. Harrison;Renato V. Iozzo.
Journal of Biological Chemistry (1996)
Structure and function of epidermal growth factor-like regions in proteins
Ettore Appella;Irene T. Weber;Francesco Blasi.
FEBS Letters (1988)
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families.
G. Velho;H. Blanché;M. Vaxillaire;C. Bellanné-Chantelot.
Diabetologia (1997)
Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus.
M Stoffel;P Froguel;J Takeda;H Zouali.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Structure of catabolite gene activator protein at 2.9-A resolution. Incorporation of amino acid sequence and interactions with cyclic AMP.
D B McKay;I T Weber;T A Steitz.
Journal of Biological Chemistry (1982)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Murdoch University
Purdue University West Lafayette
Kumamoto University
National Institutes of Health
Oak Ridge National Laboratory
National Institutes of Health
Northwestern University
National Institutes of Health
National Institutes of Health
University of North Carolina at Chapel Hill
University of Maryland, College Park
Texas A&M University
National University of Singapore
University of the Basque Country
Case Western Reserve University
Chulalongkorn University
Chinese Academy of Sciences
Radboud University Nijmegen
AsystBio (United States)
Rothamsted Research
University of Natural Resources and Life Sciences
University of Adelaide
Alfred Wegener Institute for Polar and Marine Research
Kyushu University
Jaume I University
University of Southampton